Acorda files for bankruptcy, reveals asset sale plan
Stalking horse bidder Merz Therapeutics could get rights to Acorda’s three marketed drugs if its $185 million proposal holds.
Source: yahoo.com
Merz Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Merz Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Merz Group Today - Breaking & Trending Today
Merz Enters Asset Purchase Agreement With a USBased Biotech Company
Merz Therapeutics a business of Frankfurtbased Merz Group has entered into an Asset Purchase Agreement to acquire two commercial medicines from NASDAQlisted Acorda Therapeutics.
Source: businesswireindia.com
EQS-News: Noratis AG: Noratis AG with change in the Supervisory Board
EQS-News: Noratis AG / Key word(s): Personnel/Miscellaneous Noratis AG: Noratis AG with change in the Supervisory ...
Source: businessinsider.com
Noratis AG: Noratis AG with change in the Supervisory Board
EQS-News: Noratis AG / Key word(s): Personnel/Miscellaneous Noratis AG: Noratis AG with change in the Supervisory Board 28.06.2023 / 10:00 CET/CEST The issuer is solely responsible for the content of this announ...
Source: marketscreener.com